Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PGx-guided PONV prophylaxis in bariatric surgery
NCT03503292Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- May 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of granisetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Mayo Clinic. Primary endpoints: Episodes of Postoperative Nausea and Episodes of Postoperative Vomiting. Started May 2018; status: completed.
02
Drugs
granisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03503292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503292.